Continuation of Company-Led R&D Activities
First written in FY2016-Q2. 4 of 34 entries say "Advanced", first in FY2020. Latest entry: FY2026-H1.
- FY2026-H1Interim R&D Expense UpdateAnnual report
「Total R&D expenses for the six-month consolidated accounting period were ¥52 million.」
The structure under which R&D is conducted solely by the Company was maintained, and interim-period R&D expenses were updated to ¥52 million. - FY2025Update to annual research and development expenses and activitiesAnnual report
「R&D expenses for the current consolidated fiscal year were ¥155 million.」
The structure under which R&D is conducted solely by the Company was maintained, and annual R&D expenses were updated to ¥155 million. R&D activities involving prototype AUVs, PFAS analysis, AI-based storm-surge forecasting, and digital twins were also described. - FY2025-H1Interim R&D Expense UpdateAnnual report
「Total R&D expenses for the six-month consolidated accounting period were ¥39 million.」
The structure under which R&D is conducted solely by the Company was maintained, and interim-period R&D expenses were updated to ¥39 million. - FY2024-H1Interim R&D Expense UpdateAnnual report
「Total R&D expenses for the six-month consolidated accounting period were ¥36 million.」
It was stated that there were no material changes to the structure under which R&D is conducted solely by the Company or to its R&D activities, and interim-period R&D expenses were updated to ¥36 million. - FY2024-Q1First-quarter R&D expenses updatedAnnual report
「Total R&D expenses for the three-month period ended at the first quarter of the current consolidated fiscal year were ¥7 million.」
There were no material changes to the structure under which R&D is conducted solely by the Company or to its R&D activities, while cumulative first-quarter R&D expenses were updated to ¥7 million. - FY2023AdvancedAnnual report
「R&D expenses for the current consolidated fiscal year were ¥165 million.」
R&D expenses increased from ¥157 million to ¥165 million, and specific R&D activities were described, including AUVs, AI, environmental DNA, and PFAS. - FY2023-Q3Update to R&D expenses for the first 3 quartersAnnual report
「Total R&D expenses for the nine-month period ended at the third quarter of the current consolidated fiscal year were ¥110 million.」
It was stated that R&D is conducted solely by the Company and that there were no material changes in its activities, while cumulative third-quarter R&D expenses were updated to ¥110 million. - FY2023-Q2Second-quarter R&D expenses updatedAnnual report
「Total R&D expenses for the six-month period ended at the second quarter of the current consolidated fiscal year were ¥48 million.」
There were no material changes to the structure under which R&D is conducted solely by the Company or to its R&D activities, while cumulative second-quarter R&D expenses were updated to ¥48 million. - FY2023-Q1First-quarter R&D expenses updatedAnnual report
「Total R&D expenses for the three-month period ended at the first quarter of the current consolidated fiscal year were ¥15 million.」
It was stated that there were no material changes to the structure under which R&D is conducted solely by the Company or to its R&D activities, and cumulative first-quarter R&D expenses were updated to ¥15 million. - FY2022AdvancedAnnual report
「R&D expenses for the current consolidated fiscal year were ¥157 million.」
R&D expenses were updated to ¥157 million, and specific R&D activities were described, including environmental DNA analysis, the AUV "YOUZAN," the deep-sea exploration vehicle "COEDO," and PFAS analysis. - FY2022-Q3Update to R&D expenses for the first 3 quartersAnnual report
「Total R&D expenses for the nine-month period ended at the third quarter of the current consolidated fiscal year were ¥99 million.」
It was stated that there were no material changes to the structure under which R&D is conducted solely by the Company, and cumulative third-quarter R&D expenses were updated to ¥99 million. - FY2022-Q2Second-quarter R&D expenses updatedAnnual report
「Total R&D expenses for the six-month period ended at the second quarter of the current consolidated fiscal year were ¥33 million.」
It was stated that there were no material changes to the structure under which R&D is conducted solely by the Company, and cumulative second-quarter R&D expenses were updated to ¥33 million. - FY2022-Q1First-quarter R&D expenses updatedAnnual report
「Within the Group, R&D activities are conducted solely by the Company. Total R&D expenses for the three-month period ended at the first quarter of the current consolidated fiscal year were ¥3 million. There were no material changes in R&D activities during the period.」
The absence of material changes to the structure under which R&D is conducted solely by the Company and to its R&D activities was restated, and first-quarter R&D expenses were updated to ¥3 million. - FY2021AdvancedAnnual report
「R&D expenses for the current consolidated fiscal year were ¥122 million.」
R&D expenses were updated from ¥112 million to ¥122 million. R&D activities described included the enhancement and automation of environmental DNA analysis, big data processing for urban flood risk, obstacle avoidance by the AUV "YOUZAN," and real-time flood, landslide, and inundation forecasting. - FY2021-Q3Update to R&D expenses for the first 3 quartersAnnual report
「Within the Group, R&D activities are conducted solely by the Company. Total R&D expenses for the nine-month period ended at the third quarter of the current consolidated fiscal year were ¥70 million.」
The structure under which R&D is conducted solely by the Company was maintained, and cumulative third-quarter R&D expenses were updated to ¥70 million. - FY2021-Q2Second-quarter R&D expenses updatedAnnual report
「Within the Group, R&D activities are conducted solely by the Company. Total R&D expenses for the six-month period ended at the second quarter of the current consolidated fiscal year were ¥37 million.」
The structure under which R&D is conducted solely by the Company was maintained, and cumulative second-quarter R&D expenses were updated to ¥37 million. - FY2021-Q1First-quarter R&D expenses updatedAnnual report
「Within the Group, R&D activities are conducted solely by the Company. Total R&D expenses for the three-month period ended at the first quarter of the current consolidated fiscal year were ¥4 million. There were no material changes in R&D activities during the period.」
There were no material changes to the structure under which R&D is conducted solely by the Company or to its R&D activities, while cumulative first-quarter R&D expenses were updated to ¥4 million. - FY2020AdvancedAnnual report
「R&D expenses for the current consolidated fiscal year were ¥112 million.」
R&D expenses were updated to ¥112 million, and specific R&D activities were described, including the enhancement and automation of environmental DNA analysis, AUV control, big data processing, microRNA, and VR and AR. - FY2020-Q3Update to R&D expenses for the first 3 quartersAnnual report
「Within the Group, R&D activities are conducted solely by the Company. Total R&D expenses for the nine-month period ended at the third quarter of the current consolidated fiscal year were ¥69 million.」
The structure under which R&D is conducted solely by the Company was maintained, and cumulative third-quarter R&D expenses were updated to ¥69 million. - FY2020-Q2Second-quarter R&D expenses updatedAnnual report
「Within the Group, R&D activities are conducted solely by the Company. Total R&D expenses for the six-month period ended at the second quarter of the current consolidated fiscal year were ¥33 million. There were no material changes in R&D activities during the period.」
The structure under which R&D is conducted solely by the Company was maintained, and cumulative second-quarter R&D expenses were updated to ¥33 million. - FY2020-Q1First-quarter R&D expenses updatedAnnual report
「Within the Group, R&D activities are conducted solely by the Company. Total R&D expenses for the three-month period ended at the first quarter of the current consolidated fiscal year were ¥4 million.」
The structure under which R&D is conducted solely by the Company was maintained, and cumulative first-quarter R&D expenses were stated as ¥4 million. - FY2019-Q3Update to R&D expenses for the first 3 quartersAnnual report
「Within the Group, R&D activities are conducted solely by the Company. Total R&D expenses for the nine-month period ended at the third quarter of the current consolidated fiscal year were ¥63 million. There were no material changes in R&D activities during the period.」
There were no material changes to the structure under which R&D is conducted solely by the Company or to its R&D activities, and cumulative third-quarter R&D expenses were updated to ¥63 million. - FY2019-Q2Second-quarter R&D expenses updatedAnnual report
「Within the Group, R&D activities are conducted solely by the Company. Total R&D expenses for the six-month period ended at the second quarter of the current consolidated fiscal year were ¥29 million. There were no material changes in R&D activities during the period.」
There were no changes to the structure under which R&D is conducted solely by the Company, and cumulative second-quarter R&D expenses were updated to ¥29 million. - FY2019-Q1First-quarter R&D expenses updatedAnnual report
「Within the Group, R&D activities are conducted solely by the Company. Total R&D expenses for the three-month period ended at the first quarter of the current consolidated fiscal year were ¥5 million.」
The structure under which R&D is conducted solely by the Company was maintained, and cumulative first-quarter R&D expenses were stated as ¥5 million. - FY2018-Q3Update to R&D expenses for the first 3 quartersAnnual report
「Within the Group, R&D activities are conducted solely by the Company. Total R&D expenses for the nine-month period ended at the third quarter of the current consolidated fiscal year were ¥62 million.」
The structure under which R&D is conducted solely by the Company was maintained, and cumulative third-quarter R&D expenses were updated to ¥62 million. - FY2018-Q2Second-quarter R&D expenses updatedAnnual report
「Within the Group, R&D activities are conducted solely by the Company. Total R&D expenses for the six-month period ended at the second quarter of the current consolidated fiscal year were ¥35 million.」
The structure under which R&D is conducted solely by the Company was maintained, and cumulative second-quarter R&D expenses were updated to ¥35 million. - FY2018-Q1First-quarter R&D expenses updatedAnnual report
「Within the Group, R&D activities are conducted solely by the Company. Total R&D expenses for the three-month period ended at the first quarter of the current consolidated fiscal year were ¥3 million.」
The structure under which R&D is conducted solely by the Company was maintained, and cumulative first-quarter R&D expenses were updated to ¥3 million. - FY2017Update to annual research and development expenses and activitiesAnnual report
「Research and development expenses for the consolidated fiscal year were ¥90 million.」
The structure under which R&D is conducted solely by the Company was maintained, and annual R&D expenses were updated to ¥90 million. - FY2017-Q3Update to R&D expenses for the first 3 quartersAnnual report
「Total R&D expenses for the nine-month period ended at the third quarter of the current consolidated fiscal year were ¥52 million. There were no material changes in R&D activities during the period.」
There were no material changes in R&D activities, while the cumulative third-quarter R&D expenses were updated to ¥52 million. - FY2017-Q2Second-quarter R&D expenses updatedAnnual report
「Total R&D expenses for the six-month period ended at the second quarter of the current consolidated fiscal year were ¥28 million. There were no material changes in R&D activities during the period.」
There were no material changes in R&D activities, while the cumulative second-quarter R&D expenses were updated to ¥28 million. - FY2017-Q1First-quarter R&D expenses updatedAnnual report
「Within the Group, research and development activities are conducted solely by the Company. Total research and development expenses for the three months ended the first quarter were ¥0 million. There were no material changes in the status of research and development activities during the three months ended the first quarter.」
There were no changes to the structure under which research and development is conducted solely by the Company, while research and development expenses for the three months ended the first quarter were ¥0 million. - FY2016Update to annual research and development expenses and activitiesAnnual report
「Within the Group, research and development activities are conducted solely by the Company. Research and development expenses for the fiscal year were ¥105 million.」
The Company maintained its structure of conducting research and development on a standalone basis, and reported annual research and development expenses of ¥105 million. - FY2016-Q3Increase in R&D expensesAnnual report
「Within the Group, research and development activities are conducted solely by the Company. Total research and development expenses for the nine months ended the third quarter were ¥55 million. There were no material changes in the status of research and development activities during the nine months ended the third quarter.」
There were no material changes to the structure or activities under which research and development is conducted solely by the Company, while research and development expenses were ¥55 million. - FY2016-Q2First statedAnnual report
「Within the Group, research and development activities are conducted solely by the Company. Total research and development expenses for the six months ended the second quarter were ¥31 million. There were no material changes in the status of research and development activities during the six months ended the second quarter.」
Research and development is conducted solely by the Company, and research and development expenses for the six months ended the second quarter were reported as ¥31 million.